Insight Molecular Diagnostics Inc. (IMDX) › Operating IncomeInsight Molecular Diagnostics Inc. (IMDX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2014: -$4.97M2015: -$8.72M2016: -$11.14M2017: -$18.85M2018: -$15.20M2019: -$22.24M2020: -$29.71M2021: -$53.73M2022: -$18.00M2023: -$25.14M2024: -$61.04M2025: -$51.12M-$51.12M2014Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$51.12M+16.2%2024-$61.04M-142.8%2023-$25.14M-39.7%2022-$18.00M+66.5%2021-$53.73M-80.8%2020-$29.71M-33.6%2019-$22.24M-46.3%2018-$15.20M+19.3%2017-$18.85M-69.2%2016-$11.14M-27.8%2015-$8.72M-75.3%2014-$4.97M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share